Benign Conditions urology Alpha-blocker may have benefit in larger stones July 27, 2015 By Lisette Hilton While there is no benefit from using tamsulosin (Flomax) versus placebo for the treatment of small ureteral stones, there is a potential upside of increased passage from using the drug to treat 5- to 10-mm stones, according to a study from Australia published online in the Annals of Emergency Medicine (July 13, 2015). Diet, urine pH may affect urinary tract bacterial growth July 06, 2015 By Karen Bardossi The recently published findings may open new avenues for treating urinary tract infections. Weight-loss surgery may reduce incontinence July 06, 2015 By Karen Bardossi The authors of a recently published study have found that bariatric surgery may provide a significant benefit beyond dramatic weight loss. Stone patients are poorly adherent with medical prophylaxis New findings based on pharmacy claims data show just how adherent patients are to a thiazide, alkali citrate, and allopurinol. MET found safe, efficacious in pregnant stone patients July 01, 2015 By Mac Overmyer New study data suggest an answer to the problem of managing stones in pregnant women. Ultrasound stone repositioning facilitates passage July 01, 2015 By Mac Overmyer The first clinical trial of a novel ultrasound technology shows that it can safely reposition stones in situ to make them more amenable to natural passage and treatment. Overactive bladder: Two drugs found better than one June 15, 2015 By Karen Bardossi A two-drug treatment regimen works better than monotherapy for incontinent overactive bladder patients, researchers reported at the AUA annual meeting in New Orleans. Medical expulsive therapy ineffective for ureteral stones June 01, 2015 By Lisette Hilton A large, multicenter study “definitively demonstrates” the treatment’s infectiveness, one expert says. BPH technique efficacious even in severe obstruction A patient follow-up report shows promising mid-term results from five German urology centers that implemented the prostatic urethral lift (UroLift System, NeoTract, Inc.) to alleviate symptomatic BPH in patients suffering from mild, moderate, and even severe obstruction. Cyclosporine A found efficacious for refractory IC April 01, 2015 By John Schieszer Long-term cyclosporine A therapy may be an effective treatment option for refractory interstitial cystitis, say researchers from Brazil.